A phase 1 trial of abexinostat with ibrutinib in relapsed/refractory mantle cell lymphoma and non-germinal center diffuse large B cell lymphoma.
Saved in:
| Title: | A phase 1 trial of abexinostat with ibrutinib in relapsed/refractory mantle cell lymphoma and non-germinal center diffuse large B cell lymphoma. |
|---|---|
| Authors: | Gurumurthi, Ashwath1 (AUTHOR), Bantilan, Kurt S.1 (AUTHOR), Hamlin, Paul A.1 (AUTHOR), Kumar, Anita1 (AUTHOR), Matasar, Matthew1,2 (AUTHOR), Zhu, Menglei3 (AUTHOR), Joseph, Ashlee1 (AUTHOR), Castro, Ali1 (AUTHOR), Biggar, Erin1 (AUTHOR), Salles, Gilles1 (AUTHOR), Zelenetz, Andrew D.1 (AUTHOR) zeleneta@mskcc.org, von Keudell, Gottfried1,4 (AUTHOR) |
| Source: | Leukemia & Lymphoma. Dec2024, Vol. 65 Issue 14, p2224-2227. 4p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
